Average Insider

Where insiders trade, we follow

Amylyx Pharmaceuticals, Inc. ($AMLX)
Accession: 0001193125-26-017057
Jan 21, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$3.11
Current$13.8174.4% above low, 25.6% below high
52W High$17.49

Filing Information

Accession Number0001193125-26-017057
Form Type4
Filing DateJan 21, 2026
Document DateJan 15, 2026
DocumentView SEC Filing
Transactions
6
Total Shares
538,167
Total Value
$3,392,093.81

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Cohen Joshua B
Director
Common Stock
โ€”Jan 15, 2026Exercise/Conversion197,182$7.57$1,492,667.743,514,814Directโ€”View Details
Cohen Joshua B
Director
Common Stock
โ€”Jan 15, 2026Sale136,193$13.59$1,850,794.773,378,621Directโ€”View Details
Cohen Joshua B
Director
Common Stock
โ€”Jan 16, 2026Exercise/Conversion2,818$7.57$21,332.263,381,439Directโ€”View Details
Cohen Joshua B
Director
Common Stock
โ€”Jan 16, 2026Sale1,974$13.83$27,299.043,379,465Directโ€”View Details
Cohen Joshua B
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeJan 15, 2026Exercise/Conversion197,182$0.00$0.002,818Directโ€”View Details
Cohen Joshua B
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeJan 16, 2026Exercise/Conversion2,818$0.00$0.000Directโ€”View Details
Version: v26.3.25